Latent Tuberculosis Infection (LTBI) Testing Market Report

China Latent Tuberculosis Infection (LTBI) Testing Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：227
  • REPORT CODE：GMM1829127
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Latent Tuberculosis Infection (LTBI) Testing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Agilent Technologies

    • Roche

    • Abbott Laboratories

    • Danaher

    • Bio-Rad Laboratories

    • Thermo Fisher Scientific

    • BioMerieux

    • Becton Dickinson

    • Eppendorf

    By Type:

    • Interferon Gamma Released Assay (IGRA)

    • Tuberculin Skin Test (TST)

    • Others

    By Application:

    • Household Contacts with Pulmonary TB

    • Others

    • PLHIV

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Latent Tuberculosis Infection (LTBI) Testing Market Overview 2018-2029

    • 1.1 China Latent Tuberculosis Infection (LTBI) Testing Industry Development Overview

    • 1.2 China Latent Tuberculosis Infection (LTBI) Testing Industry Development History

    • 1.3 China Latent Tuberculosis Infection (LTBI) Testing Industry Market Size (2018-2029)

    • 1.4 China Latent Tuberculosis Infection (LTBI) Testing Market Analysis by Type from Production Side

      • 1.4.1 China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Interferon Gamma Released Assay (IGRA) (2018-2029)

      • 1.4.2 China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Tuberculin Skin Test (TST) (2018-2029)

      • 1.4.3 China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Latent Tuberculosis Infection (LTBI) Testing Market Analysis by Application from Consumption End

      • 1.5.1 China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of Household Contacts with Pulmonary TB (2018-2029)

      • 1.5.2 China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of PLHIV (2018-2029)

    • 1.6 China Latent Tuberculosis Infection (LTBI) Testing Market Analysis by Region

      • 1.6.1 North China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    Chapter 2 China Latent Tuberculosis Infection (LTBI) Testing Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Latent Tuberculosis Infection (LTBI) Testing Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Latent Tuberculosis Infection (LTBI) Testing Market Status and Competition Analysis in 2023

      • 2.2.3 China Latent Tuberculosis Infection (LTBI) Testing Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Latent Tuberculosis Infection (LTBI) Testing Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Latent Tuberculosis Infection (LTBI) Testing Industry Development

    Chapter 3 Latent Tuberculosis Infection (LTBI) TestingIndustry Chain Analysis

    • 3.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain

    • 3.2 Latent Tuberculosis Infection (LTBI) Testing Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Latent Tuberculosis Infection (LTBI) Testing Market

    • 3.3 Latent Tuberculosis Infection (LTBI) Testing Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Latent Tuberculosis Infection (LTBI) Testing Market

    Chapter 4 China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 4.1 China Latent Tuberculosis Infection (LTBI) Testing Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Latent Tuberculosis Infection (LTBI) Testing Total Production Volume and Growth Rate from Production Side

    • 4.5 China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate, by Type

      • 4.5.1 China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Interferon Gamma Released Assay (IGRA)

      • 4.5.2 China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Tuberculin Skin Test (TST)

      • 4.5.3 China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Others

    Chapter 5 China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Latent Tuberculosis Infection (LTBI) Testing Total Market Size and Growth Rate from Consumption End

    • 5.5 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate, by Application

      • 5.5.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Household Contacts with Pulmonary TB

      • 5.5.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others

      • 5.5.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of PLHIV

    Chapter 6 China Latent Tuberculosis Infection (LTBI) Testing Market, by Region

    • 6.1 China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Production Value, by Region

    • 6.2 China Latent Tuberculosis Infection (LTBI) Testing Sales Volume and Sales Value, by Region

    Chapter 7 North China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 7.1 North China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 7.2 North China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 8 Central China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 8.1 Central China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 8.2 Central China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 9 South China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 9.1 South China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 9.2 South China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 10 East China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 10.1 East China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 10.2 East China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 11 Northeast China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 11.1 Northeast China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 11.2 Northeast China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 12 Southwest China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 12.1 Southwest China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 12.2 Southwest China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 13 Northwest China Latent Tuberculosis Infection (LTBI) Testing Market Analysis

    • 13.1 Northwest China Latent Tuberculosis Infection (LTBI) Testing Market, by Type

    • 13.2 Northwest China Latent Tuberculosis Infection (LTBI) Testing Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Agilent Technologies

        • 14.1.1 Agilent Technologies Company Profile

        • 14.1.2 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Roche

        • 14.2.1 Roche Company Profile

        • 14.2.2 Roche Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Abbott Laboratories

        • 14.3.1 Abbott Laboratories Company Profile

        • 14.3.2 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Danaher

        • 14.4.1 Danaher Company Profile

        • 14.4.2 Danaher Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bio-Rad Laboratories

        • 14.5.1 Bio-Rad Laboratories Company Profile

        • 14.5.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Thermo Fisher Scientific

        • 14.6.1 Thermo Fisher Scientific Company Profile

        • 14.6.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BioMerieux

        • 14.7.1 BioMerieux Company Profile

        • 14.7.2 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Becton Dickinson

        • 14.8.1 Becton Dickinson Company Profile

        • 14.8.2 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Eppendorf

        • 14.9.1 Eppendorf Company Profile

        • 14.9.2 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Latent Tuberculosis Infection (LTBI) Testing Industry Research Conclusions

    • 15.2 Latent Tuberculosis Infection (LTBI) Testing Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Industry Market Size (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Interferon Gamma Released Assay (IGRA) (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Tuberculin Skin Test (TST) (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of Household Contacts with Pulmonary TB (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Sales Volume, Sales Value and Growth Rate of PLHIV (2018-2029)

    • Figure North China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure Central China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure South China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure East China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate from 2018-2029

    • Figure Latent Tuberculosis Infection (LTBI) Testing Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type in 2018

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type in 2023

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Interferon Gamma Released Assay (IGRA) (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Tuberculin Skin Test (TST) (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2018

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2023

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Total Market Size and Growth Rate from Consumption End

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Household Contacts with Pulmonary TB (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of PLHIV (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Region (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Production Value by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Production Value Share by Region (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Production Value Share by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Region (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Sales Value by Region (2018-2023)

    • Table China Latent Tuberculosis Infection (LTBI) Testing Sales Value Share by Region (2018-2023)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Sales Value Share by Region (2018-2023)

    • Table North China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table North China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure North China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table North China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table North China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure North China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table Central China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table Central China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure Central China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table Central China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table Central China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure Central China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table South China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table South China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure South China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table South China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table South China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure South China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table East China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table East China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure East China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table East China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table East China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure East China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table Northeast China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table Northeast China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure Northeast China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table Northeast China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table Northeast China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table Southwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table Southwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure Southwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table Southwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table Southwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table Northwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume by Type (2018-2023)

    • Table Northwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Figure Northwest China Latent Tuberculosis Infection (LTBI) Testing Production Volume Share by Type (2018-2023)

    • Table Northwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume by Application (2018-2023)

    • Table Northwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Latent Tuberculosis Infection (LTBI) Testing Sales Volume Share by Application (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Danaher Company Profile

    • Table Danaher Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories Company Profile

    • Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table BioMerieux Company Profile

    • Table BioMerieux Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Becton Dickinson Company Profile

    • Table Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)

    • Table Eppendorf Company Profile

    • Table Eppendorf Latent Tuberculosis Infection (LTBI) Testing Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US